Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 63Breast Neoplasms 28Neoplasms 5Neoplasm Metastasis 3Leiomyoma 3Cardiovascular Diseases 3Polycystic Ovary Syndrome 2Neoplasms by Site 2Endometrial Neoplasms 2Breast Diseases 2Advanced Breast Cancer 2Stage II Prostate Adenocarcinoma 1Sleep Wake Disorders 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sarcopenia 1Salivary Gland Neoplasms 1Salivary Gland Adenoma, Pleomorphic 1Prostatic Neoplasms, Castration-Resistant 1Prostatectomy 1Prostate Cancer With ≤10 Bone Metastases 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Pelvic Pain 1Ovarian Neoplasms 1Osteoporosis 1Oligometastatic Prostate Carcinoma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Metastatic Neuroendocrine Prostate Cancer 1

Interventions

Toremifene 1Tamoxifen 1Ovariectomy 1Gonadotropin-Releasing Hormone 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hormone-receptor-positive Breast Cancer × Gonadotropin-Releasing Hormone × Clear all
NCT05801705 2023-05-18

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown
700 enrolled
Breast

Hormone-receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡